Hatch-Waxman Act Suits Set For 9-Year Low In 2021
Drugmakers have filed 214 suits accusing generic companies of infringement under the Hatch-Waxman Act so far in 2021, setting this year up to have the fewest number of these suits in...To view the full article, register now.
Already a subscriber? Click here to view full article